nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0914	0.146	CbGbCtD
Tasosartan—CYP3A4—Dapsone—systemic lupus erythematosus	0.0799	0.128	CbGbCtD
Tasosartan—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0693	0.111	CbGbCtD
Tasosartan—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0693	0.111	CbGbCtD
Tasosartan—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0594	0.0949	CbGbCtD
Tasosartan—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0586	0.0937	CbGbCtD
Tasosartan—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0556	0.0888	CbGbCtD
Tasosartan—CYP3A4—Prednisone—systemic lupus erythematosus	0.0554	0.0885	CbGbCtD
Tasosartan—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0525	0.0839	CbGbCtD
Tasosartan—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0346	0.0552	CbGbCtD
Tasosartan—AGTR2—kidney—systemic lupus erythematosus	0.0296	0.19	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.0221	0.103	CbGpPWpGaD
Tasosartan—AGTR2—lung—systemic lupus erythematosus	0.021	0.135	CbGeAlD
Tasosartan—AGTR1—endothelium—systemic lupus erythematosus	0.0165	0.106	CbGeAlD
Tasosartan—AGTR1—blood plasma—systemic lupus erythematosus	0.0146	0.094	CbGeAlD
Tasosartan—CYP3A4—urine—systemic lupus erythematosus	0.0103	0.0661	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.0103	0.048	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL21—systemic lupus erythematosus	0.00869	0.0406	CbGpPWpGaD
Tasosartan—AGTR1—connective tissue—systemic lupus erythematosus	0.00779	0.05	CbGeAlD
Tasosartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.00755	0.0485	CbGeAlD
Tasosartan—AGTR1—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.00719	0.0336	CbGpPWpGaD
Tasosartan—AGTR2—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.00679	0.0317	CbGpPWpGaD
Tasosartan—AGTR1—kidney—systemic lupus erythematosus	0.00663	0.0426	CbGeAlD
Tasosartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.00646	0.0415	CbGeAlD
Tasosartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.0057	0.0366	CbGeAlD
Tasosartan—CYP3A4—blood plasma—systemic lupus erythematosus	0.00537	0.0345	CbGeAlD
Tasosartan—AGTR1—tendon—systemic lupus erythematosus	0.00535	0.0344	CbGeAlD
Tasosartan—AGTR1—lung—systemic lupus erythematosus	0.0047	0.0302	CbGeAlD
Tasosartan—AGTR2—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.00465	0.0217	CbGpPWpGaD
Tasosartan—AGTR1—nervous system—systemic lupus erythematosus	0.00435	0.0279	CbGeAlD
Tasosartan—AGTR1—Allograft Rejection—C4A—systemic lupus erythematosus	0.00424	0.0198	CbGpPWpGaD
Tasosartan—AGTR1—central nervous system—systemic lupus erythematosus	0.00419	0.0269	CbGeAlD
Tasosartan—AGTR2—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.004	0.0187	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00371	0.0173	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ETS1—systemic lupus erythematosus	0.00368	0.0172	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.00335	0.0156	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00319	0.0149	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00318	0.0148	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.00297	0.0139	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.00269	0.0126	CbGpPWpGaD
Tasosartan—CYP3A4—kidney—systemic lupus erythematosus	0.00244	0.0156	CbGeAlD
Tasosartan—AGTR2—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.00242	0.0113	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.00234	0.0109	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.00221	0.0103	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00218	0.0102	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.00217	0.0101	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00214	0.00999	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.00214	0.00997	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.0021	0.00979	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD40—systemic lupus erythematosus	0.00207	0.00968	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.00204	0.00954	CbGpPWpGaD
Tasosartan—Losartan—ACE—systemic lupus erythematosus	0.00192	0.445	CrCbGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00187	0.00876	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00184	0.00861	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.0018	0.00841	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.0018	0.0084	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—systemic lupus erythematosus	0.00178	0.0083	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.00171	0.00799	CbGpPWpGaD
Tasosartan—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.0017	0.00796	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	0.00168	0.00786	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00167	0.0078	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00163	0.00761	CbGpPWpGaD
Tasosartan—Valsartan—ALB—systemic lupus erythematosus	0.00161	0.373	CrCbGaD
Tasosartan—CYP3A4—nervous system—systemic lupus erythematosus	0.0016	0.0103	CbGeAlD
Tasosartan—AGTR1—Allograft Rejection—IL10—systemic lupus erythematosus	0.00159	0.00742	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD40LG—systemic lupus erythematosus	0.00159	0.00742	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL4—systemic lupus erythematosus	0.00155	0.00722	CbGpPWpGaD
Tasosartan—CYP3A4—central nervous system—systemic lupus erythematosus	0.00154	0.00988	CbGeAlD
Tasosartan—AGTR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.00151	0.00707	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—FASLG—systemic lupus erythematosus	0.00148	0.0069	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00147	0.00684	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00143	0.00669	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—FAS—systemic lupus erythematosus	0.00142	0.00665	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2RA—systemic lupus erythematosus	0.00142	0.00661	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic lupus erythematosus	0.00141	0.00659	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—C3—systemic lupus erythematosus	0.0014	0.00656	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00137	0.00639	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	0.00128	0.00597	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00126	0.00587	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00124	0.0058	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00121	0.00564	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD80—systemic lupus erythematosus	0.00118	0.00552	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—systemic lupus erythematosus	0.00113	0.00527	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00112	0.00523	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00112	0.00521	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—C3—systemic lupus erythematosus	0.00109	0.00509	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00104	0.00485	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00104	0.00484	CbGpPWpGaD
Tasosartan—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.00102	0.00476	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.00101	0.00471	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000981	0.00458	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—F2—systemic lupus erythematosus	0.000957	0.00447	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IFNG—systemic lupus erythematosus	0.000934	0.00436	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00092	0.0043	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000878	0.0041	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—systemic lupus erythematosus	0.000872	0.00407	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000858	0.00401	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000853	0.00399	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000836	0.0039	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2—systemic lupus erythematosus	0.00083	0.00388	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000788	0.00368	CbGpPWpGaD
Tasosartan—Losartan—ALB—systemic lupus erythematosus	0.000786	0.182	CrCbGaD
Tasosartan—AGTR2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000779	0.00364	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000757	0.00354	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000734	0.00343	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000712	0.00333	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—systemic lupus erythematosus	0.000705	0.00329	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000697	0.00325	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000696	0.00325	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000693	0.00324	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000681	0.00318	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CSK—systemic lupus erythematosus	0.000675	0.00315	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000672	0.00314	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000666	0.00311	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—systemic lupus erythematosus	0.000647	0.00302	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000631	0.00295	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000622	0.0029	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000619	0.00289	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000617	0.00288	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000616	0.00288	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LYN—systemic lupus erythematosus	0.000613	0.00286	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000611	0.00285	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—systemic lupus erythematosus	0.000605	0.00282	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000604	0.00282	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000602	0.00281	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.00058	0.00271	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000573	0.00267	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000564	0.00264	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—C3—systemic lupus erythematosus	0.00056	0.00261	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000557	0.0026	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000553	0.00258	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000544	0.00254	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000541	0.00253	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000531	0.00248	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000494	0.00231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—F2—systemic lupus erythematosus	0.000491	0.00229	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000485	0.00226	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000478	0.00223	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000467	0.00218	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.00046	0.00215	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000448	0.00209	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRL—systemic lupus erythematosus	0.000446	0.00209	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000446	0.00208	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000438	0.00205	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00041	0.00191	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000406	0.0019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000405	0.00189	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000404	0.00189	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000398	0.00186	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000365	0.00171	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000364	0.0017	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000364	0.0017	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000357	0.00167	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—C3—systemic lupus erythematosus	0.000355	0.00166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000338	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000333	0.00156	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000331	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—C3—systemic lupus erythematosus	0.000331	0.00154	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000329	0.00154	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000312	0.00146	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—F2—systemic lupus erythematosus	0.000312	0.00146	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000308	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.0003	0.0014	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—F2—systemic lupus erythematosus	0.00029	0.00136	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00028	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD80—systemic lupus erythematosus	0.000278	0.0013	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000278	0.0013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000272	0.00127	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000259	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000254	0.00119	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000247	0.00115	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000239	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000235	0.0011	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000231	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000226	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	0.00022	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	0.000219	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000217	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000206	0.00096	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000203	0.000946	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000201	0.00094	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000201	0.000938	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	0.0002	0.000934	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.0002	0.000933	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000197	0.00092	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000196	0.000916	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—systemic lupus erythematosus	0.000195	0.000913	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000195	0.000908	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000187	0.000872	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000185	0.000864	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000184	0.000861	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000184	0.000859	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	0.000182	0.000852	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000176	0.000823	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EP300—systemic lupus erythematosus	0.000175	0.000819	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	0.000175	0.000817	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000166	0.000776	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000161	0.000751	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	0.00016	0.000748	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000158	0.000737	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000152	0.000712	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.00015	0.000701	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	0.000145	0.000679	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000143	0.000667	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.00013	0.000605	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000119	0.000555	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000116	0.000543	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—systemic lupus erythematosus	0.000115	0.000537	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	0.00011	0.000515	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000109	0.000507	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000108	0.000504	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	0.000108	0.000503	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	9.46e-05	0.000442	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	9.07e-05	0.000424	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	8.43e-05	0.000394	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	7.65e-05	0.000358	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	7.51e-05	0.000351	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.51e-05	0.000304	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	6.37e-05	0.000297	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	6.34e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	6.03e-05	0.000282	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.01e-05	0.000281	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	5.72e-05	0.000267	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.41e-05	0.000253	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	5.34e-05	0.000249	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.97e-05	0.000232	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	3.74e-05	0.000175	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.99e-05	0.00014	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.89e-05	8.82e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.7e-05	7.93e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.62e-05	7.59e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.49e-05	6.94e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.24e-05	5.77e-05	CbGpPWpGaD
